scholarly journals Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [ 11 C ] PBR28 and Machine Learning Analysis

2021 ◽  
Author(s):  
Aurelija Jucaite ◽  
Zsolt Cselényi ◽  
William C. Kreisl ◽  
Eugenii A. Rabiner ◽  
Andrea Varrone ◽  
...  
2007 ◽  
Vol 62 (5) ◽  
pp. 468-474 ◽  
Author(s):  
Vesna Sossi ◽  
Raúl de la Fuente-Fernández ◽  
Michael Schulzer ◽  
Andre R. Troiano ◽  
Thomas J. Ruth ◽  
...  

1997 ◽  
Vol 11 (3) ◽  
pp. 251-257 ◽  
Author(s):  
Makoto Otsuka ◽  
Yasuo Kuwabara ◽  
Yuichi Ichiya ◽  
Sinichi Hosokawa ◽  
Masayuki Sasaki ◽  
...  

2016 ◽  
Vol 30 (8) ◽  
pp. 579-587 ◽  
Author(s):  
Tatsuhiro Terada ◽  
Masamichi Yokokura ◽  
Etsuji Yoshikawa ◽  
Masami Futatsubashi ◽  
Satoshi Kono ◽  
...  

Synapse ◽  
2015 ◽  
Vol 69 (7) ◽  
pp. 365-374 ◽  
Author(s):  
Andrea Varrone ◽  
per Svenningsson ◽  
Petter Marklund ◽  
Helena Fatouros-Bergman ◽  
Anton Forsberg ◽  
...  

2010 ◽  
Vol 26 (1) ◽  
pp. 153-157 ◽  
Author(s):  
Estelle Dellapina ◽  
Angélique Gerdelat-Mas ◽  
Fabienne Ory-Magne ◽  
Laure Pourcel ◽  
Monique Galitzky ◽  
...  

2021 ◽  
Vol 13 ◽  
Author(s):  
Wen-biao Xian ◽  
Xin-chong Shi ◽  
Gan-hua Luo ◽  
Chang Yi ◽  
Xiang-song Zhang ◽  
...  

It is difficult to differentiate between Parkinson's disease and multiple system atrophy parkinsonian subtype (MSA-P) because of the overlap of their signs and symptoms. Enormous efforts have been made to develop positron emission tomography (PET) imaging to differentiate these diseases. This study aimed to investigate the co-registration analysis of 18F-fluorodopa and 18F-flurodeoxyglucose PET images to visualize the difference between Parkinson's disease and MSA-P. We enrolled 29 Parkinson's disease patients, 28 MSA-P patients, and 10 healthy controls, who underwent both 18F-fluorodopa and 18F-flurodeoxyglucose PET scans. Patients with Parkinson's disease and MSA-P exhibited reduced bilateral striatal 18F-fluorodopa uptake (p < 0.05, vs. healthy controls). Both regional specific uptake ratio analysis and statistical parametric mapping analysis of 18F-flurodeoxyglucose PET revealed hypometabolism in the bilateral putamen of MSA-P patients and hypermetabolism in the bilateral putamen of Parkinson's disease patients. There was a significant positive correlation between 18F-flurodeoxyglucose uptake and 18F-fluorodopa uptake in the contralateral posterior putamen of MSA-P patients (rs = 0.558, p = 0.002). Both 18F-flurodeoxyglucose and 18F-fluorodopa PET images showed that the striatum was rabbit-shaped in the healthy control group segmentation analysis. A defective rabbit-shaped striatum was observed in the 18F-fluorodopa PET image of patients with Parkinson's disease and MSA-P. In the segmentation analysis of 18F-flurodeoxyglucose PET image, an intact rabbit-shaped striatum was observed in Parkinson's disease patients, whereas a defective rabbit-shaped striatum was observed in MSA-P patients. These findings suggest that there were significant differences in the co-registration analysis of 18F-flurodeoxyglucose and 18F-fluorodopa PET images, which could be used in the individual analysis to differentiate Parkinson's disease from MSA-P.


Sign in / Sign up

Export Citation Format

Share Document